Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
SARATOGA SPRINGS, N.Y. (NEWS10) — For some adults suffering from major clinical depression, medicine won’t always be the answer. A non-invasive form of treatment, known as transcranial ...
NEW YORK (WPIX) – The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday. Spravato is a first-of-its-kind medication to ...
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...
"Treatment-resistant depression can be very complicated ... area head of Neuroscience at Johnson & Johnson Innovative Medicine, said in a statement. Patients could experience improvements ...